Christen DiPetrillo

Christen DiPetrillo, JD, PhD, is Vice President, Head of Intellectual Property at the Parker Institute for Cancer Immunotherapy (PICI), where she leads intellectual property strategy to advance the translation of innovative cancer immunotherapies. Working at the intersection of science, intellectual property, and business strategy, she partners with investigators across PICI’s network institutions, PICI leadership, and external collaborators to shape licensing opportunities, strategic partnerships, and new ventures that help bring promising discoveries closer to patients.

Before joining PICI, Christen led intellectual property initiatives at Vir Biotechnology during a period of rapid growth and commercialization and previously practiced life sciences patent law at Wilson Sonsini. Earlier in her career, she conducted research in synthetic biology and infectious diseases. Christen holds a PhD in Biological Sciences from Dartmouth College and a JD from Santa Clara University School of Law.